Livzon Pharmaceutical Group Inc. entered into Equity Transfer Agreement to acquire an additional 5% stake in Zhuhai Livzon Diagnostics Inc. from Shi Jianfeng for CNY 41 million.

Livzon Pharmaceutical Group Inc. (SZSE:000513) entered into Equity Transfer Agreement to acquire an additional 5% stake in Zhuhai Livzon Diagnostics Inc. from Shi Jianfeng for CNY 41 million on November 17, 2023. In a related transaction Livzon Pharmaceutical Group will aquire additional 3% stake in Zhuhai Livzon Diagnostics from Li Lin. After completion of both transactions, the stake of Livzon Pharmaceutical Group will increase from 39.43% to 47.43%.

The Acquisitions will be funded by internal resources of Livzon Pharmaceutical Group. Zhuhai Livzon Diagnostics reported net asset value of CNY 796.7 million as at June 30, 2023. The transaction is subject to approval from board of Livzon Pharmaceutical Group.